|||||**Trustees' Annual Report**|**Trustees' Annual Report**|**Trustees' Annual Report**|**Trustees' Annual Report**|**Trustees' Annual Report**|**Trustees' Annual Report**|**for theperiod**|**for theperiod**|**for theperiod**|**for theperiod**|**for theperiod**|||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||**From**|Period start date||||**T**<br>**o**|Period end date|||||||
||||||06|April||2021||05|April|||2022|||
||||||||||||||||||
||Section A||||Reference and administration details||||||||||||
||||||||||||||||||
|||||**Charity name**|||PSC Support||||||||||
||||||||||||||||||
||**Other names charity is known by**||||||||||||||||
||||||||||||||||||
|||**Registered charity number (if any)**|||||1175427||||||||||
||||||||||||||||||
||||**Charity's principal address**||||3 Gary O’Donnell Drive<br>Didcot<br>Oxfordshire<br>**Postcode**<br>**OX11 6BT**||||||||||
||||||||||||||||||
||||||||||||||||||
||||||||||||||**OX11 6BT**||||
||||||||||||||||||



## **Names of the charity trustees who manage the charity** 

|1<br>2<br>3<br>4<br>5<br>6<br>7<br>8<br>9<br>10<br>11<br>12<br>13<br>14<br>15<br>16<br>17<br>18<br>19<br>20|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**<br>**year**|**Name of person (or body)**<br>**entitled to appoint trustee (if**<br>**any)**|
|---|---|---|---|---|
||David Adams|||<br>Trustees|
||Roger Chapman|||Trustees|
||Martine Walmsley||Trustee from 10 May<br>2021 to 16 May2022|Trustees|
||James Gosney||Trustee until 22 April<br>2022|Trustees|
||GaryTaylor||Trustee until 12 May2021|Trustees|
||James Brown|||Trustees|
||Tim Waterson|||Trustees|
||Nick Kane|||Trustees|
||Rick Dallaway|||Trustees|
||ShelleySpence|||Trustees|
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||



**TAR** 

1 PSC Support MW20220515 



|||||
|---|---|---|---|
|||**Names of the trustees for the charity, if any, (for example, any custodian trustees)**||
|||**Name**|**Dates acted if not for whole year**|
|||||
|||||
|||||



## **Names and addresses of advisers (Optional information)** 

|**Names and addresses of advisers (Optional information)**|**Names and addresses of advisers (Optional information)**|**Names and addresses of advisers (Optional information)**|
|---|---|---|
|**Type of adviser**<br>**Name**<br>**Address**|||
|<br>**Independent**<br>**Examiner**|Stuart Bates|Wenn Townsend, Chartered Accountants, 10 Broad Street,<br>Abingdon OX14 3LH|
||||
||||
||||



## **Name of chief executive or names of senior staff members (Optional information)** 

## **Section B              Structure, governance and management** 

## **Description of the charity’s trusts** 

Constitution Type of governing document (eg. trust deed, constitution ) Charitable Incorporated Organisation How the charity is constituted (eg. trust, association, company) Trustees are appointed by existing Trustees Trustee selection methods 

- (eg. appointed by, elected by) 

## **Additional governance issues (Optional information)** 

You **may choose** to include additional information, where relevant, about: 

The Trustees are using the Charity Governance Code as a framework to build and improve on governance standards. 

- policies and procedures adopted for the induction and training of trustees; 

- the charity’s organisational structure and any wider network with which the charity works; 

- relationship with any related parties; 

- trustees’ consideration of major risks and the system and procedures to manage them. 

## **Section C                    Objectives and activities** 

**TAR** 

2 PSC Support MW20220515 



Our charitable objects are: 1. The relief of those suffering from liver diseases or disorders (in particular but without limitation PSC), and related disorders; **Summary of the objects of the** 2. The advancement of public awareness of PSC, other liver disease **charity set out in its governing document** and related disorders; and 3. The advancement of both the treatment and prevention of PSC and other liver disease and related disorders. 

The Trustees confirm that they have referred to the information contained in the Charity Commission’s general guidance on public benefit when reviewing the charity’s aims and objectives and in planning future activities. As a matter of course, reference is made to our agreed objectives to aid decision-making. 

Our prioritised short-term goals are as follows: 1.  Research `o` We will establish a pathway towards finding a cure or effective treatment for PSC 2.  Information and Support **Summary of the main activities** `o` We will provide support and information to improve the **undertaken for the public** quality of life and wellbeing of people affected by PSC **benefit in relation to these** 3.  Improving Care **objects (include within this** `o` We will advocate for the highest standards of care for **section the statutory** people living with PSC **declaration that trustees have had regard to the guidance issued by the Charity Commission on public benefit)** 

## **Additional details of objectives and activities (Optional information)** 

**TAR** 

3 PSC Support MW20220515 



A major aspect of PSC Support’s work is to fund high-quality PSC research. There is currently no known curative treatment, or treatment that is known to slow the progression of PSC. Our priorities are to support and drive the development of a curative treatment, treatment which slows the progression of PSC and treatment that alleviates the symptoms and psychological effects of PSC and improves PSC patients’ quality of life. PSC Support has published and operates a clear policy on grant-making. Our conflicts of interest policy ensures that for each research funding application, all reviewers are independent and impartial. 

**Our research strategy - what we intend to fund:** The establishment and development of: ●  Biobanking ●  Biomarkers Research into: ●  Prevalence/epidemiology ●  Aetiology and identification of subpopulations of PSC patients ●  Treatment ●  Outcomes including liver transplantation ●  Clinical trials in PSC Social research to investigate: ●  Quality of life ●  Survivorship 

- Transition to adult services 

You **may choose** to include further statements, where relevant, about: 

- policy on grantmaking; 

- policy programme related investment; 

- contribution made by volunteers. 

- Compliance and adherence 

- **How we fund research** ●  PSC Support funds high quality research related to PSC. ●  We expect investigators to disseminate the results of their research to both the general public and the scientific community. 

- ●  PSC Support encourages multi-centre, collaborative research. ●  PSC Support will encourage projects that link into other funding streams and national research priorities. 

- ●  Applications can include funding for pilot studies, funding equipment (but not IT equipment), and funding social and nursing research. 

- ●  Travel and internal audit grants will not normally be awarded except in exceptional circumstances. 

- ●  Funds will not be awarded retrospectively. 

- **The funding mechanism for PSC Support Research Project Grants** ●  The frequency and value of funds available for the Grant(s) will be determined each financial year, and are listed under information for applicants. 

- Applicants may apply for grants up to the available amount. ●  PSC Support reserves the right to offer funds to more than one applicant per round up to and including the amount of available Grant funds. 

- ●  PSC Support is an NIHR Non-Commercial Partner. PSC Support Research Project Grants can be eligible for NIHR Clinical Research Network (CRN) support. 

- **Research grant scope** ●  Worldwide 

- **PSC Support Directed Research** PSC Support also prioritises research and directs its own, patient-led research. 

**TAR** 

4 PSC Support MW20220515 



## **Contribution made by volunteers** 

Our Trustees and Treasurer are not remunerated aside from any expenses they directly incur on behalf of PSC Support. 

The Board of Trustees recognises the significant contribution to the charity made by volunteers, including Martine Walmsley, who undertakes the day-to-day management and operational activities of the charity on a full-time basis, handles the PSC Support Helpline calls and emails and moderates the Facebook group; Keith Anderson, who is the charity Treasurer; and Lorraine Failes, who is a long-standing Facebook moderator for the PSC Support Facebook group. We are also very grateful to the long-term support from Gareth and Vicki Weeks in moderating our Facebook group, to Josie and Malcolm Eddy who send out PSC Support merchandise, to Iain McClenaghan for his support as webmaster, to Noelie Srivastava for graphic design services and to all the patients and families who have provided their perspectives in this year’s support, advocacy and research initiatives. 

PSC Support works with dedicated medical professionals, who give their time and expertise to PSC Support community at no cost. This year, we are grateful for the support from: Professor David Adams, Professor Graeme Alexander, Dr Richard Aspinall, Dr Annika Bergquist, Dr Luke Boulter, Teresa Brevini, Dr Roger Chapman, Dr Clare Constantinou, Dr Emma Culver, Dr Jessica Dyson, Dr James Ferguson, Professor Michael Heneghan, Dr Deepak Joshi, Professor Ansgar Lohse, Dr Kate Lynch, Dr Elena Marcus, Dr Neil McDougall, Dr Kathy McKay, Dr Nabil Quraishi, Dr Mussarat Rahim, Dr Simon Rushbrook, Dr Fotis Sampaziotis, Dr Francesca Saffioti, Dr Christoph Schramm, Dr Keith Siau, Amanda Smith, Dr Brijesh Srivastava, Professor Douglas Thorburn, Dr Palak Trivedi, Dr Veronica Ranieri, Dr Mike Williams, and Dr Andrew Yeoman. 

## Section D                      Achievements and performance 

**TAR** 

5 PSC Support MW20220515 



## **Summary of the main achievements of the charity during the year** 

## **Fundraising** 

Voluntary fundraising income for the charity for the year ending 5 April 2022 was £184,609, of which £2,063 was restricted for research only. For reference, the total income for the year ending 5 April 2022 was £185,682. Thanks to the remarkable innovation and commitment of patients and family members, we saw a 56% increase in donations compared to 2020/21. 

## **Expenditure** 

Total expenditure for the year ending 5 April 2022 was £42,795. Activities were reviewed and funds reallocated as the financial year progressed in order to maximise value for money and use charity resources efficiently. 

## **COVID-19** 

During this financial year, the charity’s activities continued to be impacted by COVID-19. This meant travel and face-to-face meetings were infrequent, research activity in the UK continued to be affected, particularly academic research. 

## **Organisational risk, limitations and stability** 

The Trustees of PSC Support held quarterly virtual meetings and kept in close contact with the charity’s volunteers through Martine Walmsley. 

All Trustees receive copies of income and expenditure figures for the financial year to date every month from the PSC Support Treasurer. The Board also receives a full Financial Report every quarter, which takes into account the forecast, expenditure, income and any designated funds to ensure they are fully aware of the charity’s current and expected financial position as an ongoing concern. 

The charity’s part-time single member of staff (Programme Development Officer) commenced maternity leave in 2Q2021. 

Following the Trustees’ strategic decision in the previous financial year to increase the charity’s capacity by appointing a Chief Executive, recruitment began in 3Q2021. The successful candidate was appointed in February 2022, commencing work with PSC Support in May 2022. 

## **Research** 

The pandemic continued to impact the UK healthcare system and some (particularly research staff) were not appointed back to their original positions until towards end of the financial year. 

Despite this, PSC research remained a priority for PSC Support. A funding round began in March 2022 and is due to complete in May/June 2022. 

The charity also continued to dedicate time to supporting clinical trial development by working with pharmaceutical companies to ensure trial protocols and patient information were fit for purpose and appropriate for our UK community. We ended the financial year with clinical trials and research studies at 16 different sites across the UK. Additional research activities included: 1.  Being a co-applicant on national and international PSC research study funding applications; 2.  Running focus groups of 8-10 people living with PSC each at regular intervals for academic research studies and steering 6 PSC Support MW20220515 

**TAR** 



- groups. We are very grateful to the patients who joined our research panels to provide feedback to researchers; 

- 3.  Representing PSC patients in the European Reference Network (ERN RARE-LIVER) as the Co-Lead of the PSC Working Group (MW) and conducting an international patient care survey to use to advocate for higher standards in PSC patient care. 

- Publications: 

   - Fatourou E, King D, Hyde S, Walmsley M, Alexander G, Trivedi P, Rushbrook S, Thorburn D, PSC IC. PMO-35 **UK national  audit on diagnosis and management of colitis in patients with primary sclerosing cholangitis.** dx.doi.org/10.1136/gutjnl-2021-BSG.174 

   - ● Francque SM, Marchesini G, Kautz A, Walmsley M, Dorner R, Lazarus JV, Zelber-Sagi S, Hallsworth K, Busetto L, Frühbeck G, Dicker D. **Non-alcoholic fatty liver disease: A patient guideline.** JHEP Reports. 2021 Oct 1;3(5):100322. https://doi.org/10.1016/j.jhepr.2021.100322 

   - ● Zecher B, Buescher G, Willemse J, Walmsley M, Taylor A, Leburgue A, Schramm C, Lohse AW, Sebode M. **Prevalence of COVID-19  in patients with autoimmune liver disease in Europe: A patient-oriented online survey.** United European Gastroenterol  J. 2021 doi.org/10.1002/ueg2.12100 

## **Support and information** 

Because of the challenges presented by COVID-19, people living with PSC needed more support than ever. Although we could not meet face-to-face, PSC Support continued to provide timely information, resources and support through the www.pscsupport.org.uk website, news bulletins, social media, and online communities, as well as live, online presentations and Q&As (‘Ask the Expert’ sessions). 

Special thanks to the volunteers who moderate of our Facebook group and maintain our Helpline, who continued to provide support to people with PSC over all Bank Holidays, particularly holiday periods when other organisations temporarily halted support. 

## **Launch of the PSC Support App** 

The PSC Support App was launched in June 2021 to empower PSC patients to manage symptoms and hospital appointments, and get the right care at the right time. The app provides the tools to: 

- track health and symptoms 

- share health reports 

- customise questions for use in appointments 

- understand the minimum UK care standards 

- stay up-to-date with the latest PSC news and research 

- access the digital PSC Alert Card 

- access support 

We are very proud that the PSC Support App was shortlisted as a finalist for the prestigious UK App Awards in October 2021. 

## **Advocacy** 

PSC Support continued to provide strong advocacy for people affected by PSC at a national and international level. 

**TAR** 

7 PSC Support MW20220515 



|The charity ended the financial year with the following key committed|The charity ended the financial year with the following key committed|
|---|---|
|funds:||
|**Committed Designated Items**|**Amount**|
|Research Reference: 040519UKPSC "The Primary Sclerosing|£2,000|
|Cholangitis (PSC) 600: A UK-PSC Initiative" (Final 10% of grant||
|subject to satisfactoryfinal report)||
|Research Reference: 160219EG "The development of a diagnostic|£1,000|
|blood test for PSC" (Final 10% of grant subject to satisfactory final||
|report)||
|Research Reference: 20220310SREC "Validating a Diagnostic|£30,000|
|Biomarker in Primary Sclerosing Cholangitis" (subject to peer||
|reviewed application appraisal in current fundinground)||
|Research Reference: FARGO "FAecal microbiota transplantation in|£50,000|
|primaRy sclerosinG chOlangitis" (subject to satisfactory milestone||
|reports over fouryears)||
|Liver Transplant Guidelines|£2,500|
||**£85,500**|



## **Section E                    Financial review** 

|**Brief statement of the**<br>**charity’s policy on reserves**<br>**Details of any funds materially**<br>**in deficit**<br>**Further financial review details**|Our reserves policy is to maintain twelve months’ operating costs<br>(unrestricted funds) in addition to any designated funds, to enable normal<br>operating activities to continue over a period of 12 months should a<br>shortfall in income occur and to take account of potential risks and<br>contingencies that may arise from time to time.<br>This also supports decision-making when planning additional support<br>activities and making research grants. Operating costs are deemed to<br>include expected on-going support costs (including e-bulletin production,<br>website maintenance and feature enhancement, meeting costs),<br>promotional materials and general administration costs. This allows PSC<br>Support to plan additional projects whilst ensuring that operating costs<br>continue to be met.<br>In order to establish the reserve, the Trustees consider the financial<br>circumstances and risks annually (expenditure and unrestricted income).<br>The Trustees review the charity accounts monthly and the forecast on a<br>quarterly basis.<br>The Trustees regularly reviewed funds/reserves levels throughout<br>2021/22, focusing funds on the most important priorities.<br>The reserves value held by the charity (which equals one year of running<br>costs), stands at £115,613. This includes the increased pay expenditure<br>allocated to new staff.<br>PSC Support does not commit to expenditure if funding is not available.|
|---|---|
||No funds were materially in deficit.|
||**(Optional information)**|



**TAR** 

8 PSC Support MW20220515 



You **may choose** to include additional information, where relevant about: 

- the charity’s principal sources of funds (including any fundraising); 

- how expenditure has supported the key objectives of the charity; 

- investment policy and objectives including any ethical investment policy adopted. 

## **Financial position at the end of the period** 

At the end of the period, PSC Support held £401,158. The total unrestricted charity funds as at 5 April 2022 is £394,158, and restricted funds was £7,000. 

Designated funds are expenditure that the charity has ‘ringfenced’ as future spend for specific items. These funds can either be ‘committed’, where the charity has made either a formal or informal commitment to spend, or ‘flexible’, where the charity has discretion about whether it would like to proceed with the spend. At the end of 2021/22, the charity has £111,507 of designated funds, with £59,543 of these ‘committed’ and an additional £143,730 set aside for reserves. 

Research expenditure in 2021/22 was held back because of the COVID-19 pandemic. However, PSC Support’s own research activities did not slow down and by the year end, £83,000 of the designated funds was committed to specific research projects. 

## **Section F                     Other optional information** 

## **Section G                    Declaration** 

**The trustees declare that they have approved the trustees’ report above.** 

## **Signed  on behalf of the charity’s trustees** 

**Signature(s)** Tim Waterson **Full name(s)** Rick Dallaway **Position (eg Secretary,** Trustee Trustee **Chair, etc) Date** 7 October 2022 

**TAR** 

9 PSC Support MW20220515 



PSC SUPPORT
cio
- REGISTERED CHARITY NUMBER 1175427
RECEIPTS & PAYMEKfs 6th APRIL 2021 to 5th APRIL 2022
Totsl
Funds
FuThds
202
20
202
RECEIPTS
l)onations & Fund Raisi
General Donations & Fund Raising
Restricted Donationsfor PSC Research
Gift Aid Reclaimed IlncludirE Via Intemetl
I68￿30
168,830
98,986
5.550
13,422
117,958
13,716
182.546
13,779
184,609
2,063
Sale of PSC Su
rt Merchandise
Hoodies, Polo & T Shirts
Running T Shirts & Vesrs
Mugs
Pin Badge5
Wristbands
236
236
225
260
260
16
38
183
183
53
723
723
332
Other Recei
Acute Cholangitis Alert Cards- Foreign Shipping
Refund of D85 Checks Fee
Refund of EASL & ILC Conference Fees
Rehjnd of Outsvard Airfares to ECRD Stcdholm Conferen
by Ryanair
15
23
87
87
176
86
494
Interest Credited to Deposit Accounts
Reimbursement for Personal Purchase (harged to Charity's
Credtt Card in Error
237
237
350
350
778
TOTAL RECEIPTS
183.619
2.063
185.682
119,068
PAYMENTS
General Administration
Combined Charity Insurance
Credit Card Fee
Current Account Bank Charges
Data Protection Fee Ilnformation Commissioner's Offi￿)
DBS Checks on Volunteers
Microsoft Office 365 Annual Subscription
Postage
Printer Usage
Service User Surveys (SUn￿V Monkey)
Soho66 Phone Services (Admin)
552
30
552
30
590
30
12
12
35
35
94
33
36
29
33
36
33
30
29
42
306
109
306
109
306
162
Page I

Stationery
UK P05tbox
80
1,224
80
1,224
60
1,387
Staff Em
ment
Gross Salary & SMP
Home Working Broadband Allowan
Home Working Heating & Lighting Allowance
Salary Deductions for Tax. Nl, Pension & Student
16.711
336
2Crf)
16,711
336
200
22,890
392
200
Loan Repayment
{2,7091
1.374
1.621
462
12.7091
1,374
1,621
462
15,0661
4,151
2.054
546
HMRC Payments (Employee & Employer)
Pension Contribution5 (Employee & Employer)
Payroll Charges- Wenn Townsend
Credit Card Fee
Employee Training
Mobile Phone Usage
Office Equipment. Furniture. Software & SundriÈs
Recrustment o* CEO- Charisma Recruitment Ltd
Legal Costs re CEO'S Contract of Employment
30
30
25
25
24
24
96
57
57
446
S,(K)O
1,890
25,021
1,890
25.021
25,739
Alfvoca
Benefits & Work Publishing Subscription
Disability Rights UK Membership
EASL Annual Membership
Eurordis Annual Membership
Registration for Online EASL Intemational Liver Congress
RegÈstration for Online EURORDIS European ConfererKe
Genetic Alliance UK Membership
77
97
102
188
91
175
91
175
91
72
550
Awaréness & Su
A6 Flyers
Acute Cholangttis Atert Cards
B￿SL Conference- tharge for PSC Support Stand
Mailchimp Subscription for NewslÈtters
Mobile Phone Usage for Helpline IGiff Gaffl
Legal Fees re Privacy Policy & T&Cs IPatient Support Appl
Legal Fees re Privacy Policy & T&Cs IWebsiÉel
Online Helpline Booking System
Patient Support App Development IAPPOLYI
Patient Support App Hosting IAPPOLYI
Legal Fees re Staffing Helpline
Soho66 Phone SeMces1Support}
Webstte Domain Registration Renewal IFasthosts}
Website Hosting (Fasthostsl
Websitè Hosting IUpdraftPlusl
Zoom Pro Subscription
Indudi
19
234
234
122
528
56
528
56
43
1,894
3,788
56
2.940
56
2.940
14.156
1,379
77
1.379
77
89
162
ioi
126
89
162
162
54
144
144
7,219
201
20,612
7.219
Page 2

Fundraisi
A6 Flyers
Challenge Event Places (Nova)
Collection Boxes
Facebook Advertising
Fundraising Banner
Fundraising Training
Just Giving
London Marathons 2021 Entries Iwirtual & In Person)
Virtual London Marathon 2021 Competttion Prizè
PayPal Fees Deducted from Donations Received
Postage & Packaging
19
670
24
670
24
55
47
225
562
561
561
75
75
55
17
1.564
196
196
1,576
1,576
Govemance
Independent Examination of 2020/21 Accounts
Purchase & Distribution of P5C S
T Shirts
RunningT Shirts
Wristbands
Merchandise Flyers
PayPal & eBay Fees
Postage & Packaging
610
596
264
20
610
596
264
20
92
36
128
98
1.656
98
1.656
Research
Education l Research re ainical Trials
inical Trials Packs- PayPal Fees Dedutted from Donati￿
Drjesus Banales Ispainl
496
496
902
1,405
3,613
3,613
4,515
5,018
Other
nditure
Personal Purchase Charged to Charity's Credtt Card in Error
(Fully Reimbursed)
TOTAL PAYMENTS
39.182
3.613
42.795
50.587
SURPLUS / DEFICIT
144.437
11.550)
142.887
68,481
Transfers Between Restritted & Unrestricted Funds
OPENING BANK BALANCES AT 614/2021
249.721
8.550
258,271
189,790
CLOSING BANK BALANCES AT 51412022
Current Account
PayPal Account
61,030
128
61,030
128
3.228
43
Page 3

Deposit Accounts
333,tJXI
7.OlXS
340.OCKI
401.
255,(X)O
258.271
MERCHANDISE & OTHER ASSETS HELD AT S
2022
Various Office Equipment & Furniture, Mobile Phone, Various Fund Raising & Infonnational Resources, 69 T Shirts,
20 Running T Shirt5, 20 Running Vests, 55 Mugs. 725 Wristban(ts & Other Mirtor Item&
DEBTS
LIABILMES
GUARANTEES
The charrty ha5 no outstandinE debts. It has madè the following commitments:
11 It has guaranteed to pay a retained total of £3.LU) to two researthers when their projerts have been completed
to the charity's satisfartion.
21 The charity has undertaken to contribute £2,500 towards the cost of produong new UK knver Transplant Guidelines.
31 The charity has condttionally undertaken to contFibute £30.LKK) to a Diagn05tic Blood Test Research Project and
£50,000 to the FARGO PSC Research Trial.
Keith V Anderson IPSC Support Treasurer)
rimothy Waterson IPSC Support Chair of Trustees
3011212022
Date
Page 4

CHARITY COMMISSION
FOR ENGLAND AND WALES
Independent examiner's
report on the accounts
Section A
Independent Examiner's Report
Report to the trusteesl
members of
PSC SupFlOrt
On accounts for the year
ended
51h April 2022
Charlty no
(If any}
1175427
Set out on pages
1to4
I report to the trustees on my examination ofthe accounts of the above
charity {"the Trusf'} for the year ended 51h April 2022.
Responsibilltles and As the charity trustees of the Trust, you are responsible for the preparation
basis of report of the accounts in accordan￿ with the requirements of the Charities Act
2011 {"the Acr).
I report in respect of my exarnination of the Trust's accounts carried out
under section 145 of the 2011 Act and in carrying out my examination, I
have followed the applicable Directions given by the Charity Commission
under section 145(5){bl of the Act.
I have completed my examination. I confim that no material matters have
come to my attention in connection with the examination which oives me
cause to believe Ihal in, any material respect..
accounting records were not kept in accordance with sedion 130 of
the Act or
the accounts do not accord with the accounting records
Independent
examinor'8 Statomont
I have no concerns and have come across no other matters in connection
with the examination to which attention should be drawn in order to enable a
proper understanding of the accounts to be reached.
Signed".
Date:
Name:
stuart Bates
Relevant professional
qualificatlon{s) or body
(if any):
BA FCA CTA
Address:
Victoria House, 10 Broad Street
Abingdon
OX14 3LH
Section B
Disclosure
Only complete iflhe examiner needs to highlight matters of concern (see CC32,
Independent examination of ¢harity accounts.. directions and guidance for
examiners).

Givo h•r• bri•f details of
any Items that the
examiner wishes to
disclose.